|
FAM133B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.275000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.475200E-01 |
| Normal-vs-Stage2 |
5.973000E-01 |
| Normal-vs-Stage3 |
8.465800E-01 |
| Normal-vs-Stage4 |
9.722200E-01 |
| Stage1-vs-Stage2 |
7.061600E-01 |
| Stage1-vs-Stage3 |
6.283600E-01 |
| Stage1-vs-Stage4 |
7.034400E-01 |
| Stage2-vs-Stage3 |
5.067200E-01 |
| Stage2-vs-Stage4 |
5.785000E-01 |
| Stage3-vs-Stage4 |
8.651400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.704800E-01 |
| Normal-vs-AfricanAmerican |
7.959800E-01 |
| Normal-vs-Asian |
1.974430E-01 |
| Caucasian-vs-AfricanAmerican |
7.911400E-01 |
| Caucasian-vs-Asian |
1.335150E-01 |
| AfricanAmerican-vs-Asian |
7.572200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.407800E-01 |
| Normal-vs-Female |
3.142400E-01 |
| Male-vs-Female |
1.273560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.966800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.175400E-01 |
| Normal-vs-Age(61-80Yrs) |
8.320200E-01 |
| Normal-vs-Age(81-100Yrs) |
9.922400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.754600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.162600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.951430E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.441000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.938460E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.514400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.249800E-02 |
| Normal-vs-Grade 2 |
1.469770E-01 |
| Normal-vs-Grade 3 |
1.865550E-01 |
| Normal-vs-Grade 4 |
3.693000E-01 |
| Grade 1-vs-Grade 2 |
4.172200E-01 |
| Grade 1-vs-Grade 3 |
8.662200E-03 |
| Grade 1-vs-Grade 4 |
3.557700E-02 |
| Grade 2-vs-Grade 3 |
3.260900E-03 |
| Grade 2-vs-Grade 4 |
2.322300E-02 |
| Grade 3-vs-Grade 4 |
8.877200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.008410E-01 |
| Normal-vs-ccB subtype |
2.435800E-01 |
| ccA subtype-vs-ccB subtype |
4.717700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.581200E-01 |
| Normal-vs-N1 |
5.579600E-01 |
| N0-vs-N1 |
6.139000E-01 |
|
|
